Gwendalyn D. King

Gwendalyn D. King

Auto-generated profile, based on publicly available information

Gwendalyn D. King

Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2017 in eLife
Verified
Journal Article
Open access
EAElena W Adlaf
Elena W Adlaf
RVRyan J Vaden
Ryan J Vaden
ANAnastasia J Niver
Anastasia J Niver
AMAllison F Manuel
Allison F Manuel
VOVincent C Onyilo
Vincent C Onyilo
LOLinda Overstreet-Wadiche
Linda Overstreet-Wadiche
Adult-born neurons are continually produced in the dentate gyrus but it is unclear whether synaptic integration of new neurons affects the pre-existing circuit. Here we investigated how manipulating neurogenesis in adult mice alters excitatory synaptic transmission to mature dentate neurons. Enhancing neurogenesis by conditional deletion of the pro-apoptotic gene Bax in stem cells reduced excitatory postsynaptic currents (EPSCs) and spine density in mature neurons, whereas genetic ablation of neurogenesis increased EPSCs in mature neurons. Unexpectedly, we found that Bax deletion in developing and mature dentate neurons increased EPSCs and prevented neurogenesis-induced synaptic suppression. Together these results show that neurogenesis modifies synaptic transmission to mature neurons in a manner consistent with a redistribution of pre-existing synapses to newly integrating neurons and that a non-apoptotic function of the Bax signaling pathway contributes to ongoing synaptic refinement within the dentate circuit.

1 August 2013 in Brain Research
Verified
Journal Article
Closed access
SCSarah M. Clinton
Sarah M. Clinton
MGMatthew E. Glover
Matthew E. Glover
AMAstha Maltare
Astha Maltare
ALAnn M. Laszczyk
Ann M. Laszczyk
SMStephen J. Mehi
Stephen J. Mehi
GKGwendalyn D. King
Gwendalyn D. King

1 November 2017 in Neurobiology of Aging
Verified
Journal Article
Closed access
ALAnn M. Laszczyk
Ann M. Laszczyk
SFStephanie Fox-Quick
Stephanie Fox-Quick
HVHai T. Vo
Hai T. Vo
DNDailey Nettles
Dailey Nettles
PPPhyllis C. Pugh
Phyllis C. Pugh
GKGwendalyn D. King
Gwendalyn D. King

10 January 2015 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
JVJada H Vaden
Jada H Vaden
BBBula J Bhattacharyya
Bula J Bhattacharyya
PCPing-Chung Chen
Ping-Chung Chen
JWJennifer A Watson
Jennifer A Watson
AMAndrea G Marshall
Andrea G Marshall
SWScott M Wilson
Scott M Wilson
Ubiquitin-specific protease 14 (USP14) is one of three proteasome-associated deubiquitinating enzymes that remove ubiquitin from proteasomal substrates prior to their degradation. In vitro evidence suggests that inhibiting USP14’s catalytic activity alters the turnover of ubiquitinated proteins by the proteasome, although whether protein degradation is accelerated or delayed seems to be cell-type and substrate specific. For example, combined inhibition of USP14 and the proteasomal deubiquitinating enzyme UCH37 halts protein degradation and promotes apoptosis in multiple myeloma cells, whereas USP14 inhibition alone accelerates the degradation of aggregate-prone proteins in immortalized cell lines. These findings have prompted interest in USP14 as a therapeutic target both inside and outside of the nervous system. However, loss of USP14 in the spontaneously occurring ataxia mouse mutant leads to a dramatic neuromuscular phenotype and early perinatal lethality, suggesting that USP14 inhibition may have adverse consequences in the nervous system. We therefore expressed a catalytically inactive USP14 mutant in the mouse nervous system to determine whether USP14’s catalytic activity is required for neuromuscular junction (NMJ) structure and function. Mice expressing catalytically inactive USP14 in the nervous system exhibited motor deficits, altered NMJ structure, and synaptic transmission deficits that were similar to what is observed in the USP14-deficient ataxia mice. Acute pharmacological inhibition of USP14 in wild type mice also reduced NMJ synaptic transmission. However, there was no evidence of altered proteasome activity when USP14 was inhibited either genetically or pharmacologically. Instead, these manipulations increased the levels of non-proteasome targeting ubiquitin conjugates. Specifically, we observed enhanced proteasome-independent ubiquitination of mixed lineage kinase 3 (MLK3). Consistent with the direct activation of MLK3 by ubiquitination, we also observed increased activation of its downstrea targets MAP kinase kinase 4 (MKK4) and c-Jun N-terminal kinase (JNK). In vivo inhibition of JNK improved motor function and synapse structure in the USP14 catalytic mutant mice. USP14’s catalytic activity is required for nervous system structure and function and has an ongoing role in NMJ synaptic transmission. By regulating the ubiquitination status of protein kinases, USP14 can coordinate the activity of intracellular signaling pathways that control the development and activity of the NMJ.

1 December 2017 in Brain Plasticity
Verified
Journal Article
Open access
PDF file
HVHai T. Vo
Hai T. Vo
ALAnn M. Laszczyk
Ann M. Laszczyk
GKGwendalyn D. King
Gwendalyn D. King
Brain expression of klotho was first described with the initial discovery of the klotho gene. The prominent age-regulating effects of klotho are attributed to regulation of ion homeostasis through klotho function in the kidney. However, recent advances identified brain functions and cell populations, including adult hippocampal neural progenitors, which require klotho. As well, both human correlational studies and mouse models of disease show that klotho is protective against multiple neurological and psychological disorders. This review focuses on current knowledge as to how the klotho protein effects the brain.

1 October 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
NRNicholas J. Reish
Nicholas J. Reish
AMAstha Maltare
Astha Maltare
AMAlex S. McKeown
Alex S. McKeown
ALAnn M. Laszczyk
Ann M. Laszczyk
TKTimothy W. Kraft
Timothy W. Kraft
GKGwendalyn D. King
Gwendalyn D. King
Purpose. To determine whether the age-regulating protein klotho was expressed in the retina and determine whether the absence of klotho affected retinal function. Methods. Immunohistochemistry and qPCR of klotho knockout and wild-type mice were used to detect klotho expression in retina. Immunohistochemistry was used to probe for differences in expression of proteins important in synaptic function, retinal structure, and ionic flux. Electroretinography (ERG) was conducted on animals across lifespan to determine whether decreased klotho expression affects retinal function. Results. Klotho mRNA and protein were detected in the wild-type mouse retina, with protein present in all nuclear layers. Over the short lifespan of the knockout mouse (∼8 weeks), no overt photoreceptor cell loss was observed, however, function was progressively impaired. At 3 weeks of age neither protein expression levels (synaptophysin and glutamic acid decarboxylase [GAD67]) nor retinal function were distinguishable from wild-type controls. However, by 7 weeks of age expression of synaptophysin, glial fibrillary acidic protein (GFAP), and transient receptor potential cation channel subfamily member 1 (TRPM1) decreased while GAD67, post synaptic density 95 (PSD95), and wheat germ agglutinin staining, representative of glycoprotein sialic acid residues, were increased relative to wild-type mice. Accompanying these changes, profound functional deficits were observed as both ERG a-wave and b-wave amplitudes compared with wild-type controls. Conclusions. Klotho is expressed in the retina and is important for healthy retinal function. Although the mechanisms for the observed abnormalities are not known, they are consistent with the accelerating aging phenotype seen in other tissues.